| Literature DB >> 32438585 |
Gisela A González-Montiel1, Elizabeth N Kaweesa1,2, Nicolas Feau3, Richard C Hamelin3,4, Jeffrey K Stone5, Sandra Loesgen1,2.
Abstract
We report the first secondary metabolite, 8,8'-bijuglone, obtained from pure cultures of the slow growing Douglas fir- (Pseudotsuga menziesii var. menziesii) foliage-associated fungus Zasmidium pseudotsugae. The quinone was characterized using extensive LC/MS and NMR-based spectroscopic methods. 8,8'-Bijuglone exhibited moderate antibiotic activity against Gram-positive pathogens and weak cytotoxic activity in the NCI-60 cell line panel and in our in-house human colon carcinoma (HCT-116) cell line. An analysis of the fungal genome sequence to assess its metabolic potential was implemented using the bioinformatic tool antiSMASH. In total, 36 putative biosynthetic gene clusters were found with a majority encoding for polyketides (17), followed by non-ribosomal peptides (14), terpenes (2), ribosomal peptides (1), and compounds with mixed biosynthetic origin (2). This study demonstrates that foliage associated fungi of conifers produce antimicrobial metabolites and suggests this guild of fungi may present a rich source of novel molecules.Entities:
Keywords: 8,8′-bijuglone; Mycosphaerellaceae; Zasmidium pseudotsugae; cytotoxic activity; epiphytic fungi; genome mining; quinone
Mesh:
Substances:
Year: 2020 PMID: 32438585 PMCID: PMC7287617 DOI: 10.3390/molecules25102358
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
1H and 13C NMR of 8,8′-bijuglone (1) at 500 MHz in CDCl3.
| Compound |
| ||
|---|---|---|---|
| Position | δC | Type | δH, mult ( |
| 1, 1′ | 184.9 | C | - |
| 2, 2′ | 140.6 | CH | 6.71, d (10.2 Hz) |
| 3, 3′ | 138.0 | CH | 6.92, d (10.2 Hz) |
| 4, 4′ | 190.8 | C | - |
| 4a, 4a′ | 115.5 | C | - |
| 5, 5′ | 161.9 | C | - |
| 6, 6′ | 124.8 | CH | 7.31, d (8.7 Hz) |
| 7, 7′ | 138.7 | CH | 7.24, d (8.7 Hz) |
| 8, 8′ | 135.2 | C | - |
| 8a, 8a′ | 128.3 | C | - |
| 5-OH, 5′-OH | - | - | 12.49, s |
Figure 1Biosynthetic gene clusters predicted in Z. pseudotsugae identified by antiSMASH. Clusters with 100% similarity to a compound are shown on the right. The structure of 8,8′-bijuglone (1) is highlighted in blue in the core structures of cercosporin and elsinochrome.
Antimicrobial activity of 8,8′-bijuglone (1). Percent given is cell survival after treatment. Pathogens used: methicillin-resistant Staphylococcus aureus (BAA-44) = MRSA, Bacillus subtilis (ATCC 49343), Mycobacterium smegmatis (ATCC 14468), Escherichia coli (ATCC 8739), Pseudomonas aeruginosa (ATCC 15442), Candida albicans (ATCC 90027).
| Sample 1 | Antibacterial 2 | Antifungal 2 | ||||
|---|---|---|---|---|---|---|
| MRSA |
|
|
|
|
| |
| 8,8′-bijuglone | 29.3% | 32.6% | 91.5% | 97.1% | 86.0% | 99.5% |
| positive control | 0.0% vancomycin | 15.1% chloramphenicol | 1.5% rifampicin | 11.6% ampicillin | 0.2% kanamycin | 23.6% amphotericin B |
| negative control | > 100% ethanol | 68% ethanol | 100% DMSO | 89.0% ethanol | 92.4% ethanol | 100% ethanol |
1 Samples and positive controls were tested to a final concentration of 125 µg/mL [360 µM]. Negative controls were tested at 1.25% ethanol, except M. smegmatis in DMSO.
Figure 2IC50 curve of 8,8′-bijuglone (1) against human colon carcinoma (HCT-116). The IC50 value was determined to be 130 µM (0.13 mM, 45 µg/mL).
Figure 3Mean graph display of NCI-60 cell line screening data for 8,8′-bijuglone (1) (NCS 811277). Sample concentration at 10 µM. The bars to the right indicate high lethality and the bars to the left indicate growth inhibition. Experiments were performed at the NCI-DTP: http://dtp.cancer.gov [44].